Plasma membrane expression of ZNF185 is a prognostic factor in pancreatic ductal carcinoma

被引:4
|
作者
Furukawa, Daisuke [1 ,2 ,3 ]
Chijiwa, Tsuyoshi [4 ]
Matsuyama, Masahiro [3 ]
Mukai, Masaya [5 ]
Matsuo, Ei-Ichi [6 ]
Nishimura, Osamu [7 ]
Kawai, Kenji [4 ]
Suemizu, Hiroshi [4 ]
Nakagohri, Toshio [3 ]
Ozawa, Soji [3 ]
Shimada, Kazuaki [8 ]
Hiraoka, Nobuyoshi [1 ,2 ]
Nakamura, Masato [9 ]
机构
[1] Natl Canc Ctr, Res Inst, Div Pathol & Clin Labs, Tokyo 1040045, Japan
[2] Natl Canc Ctr, Res Inst, Div Mol Pathol, Tokyo 1040045, Japan
[3] Tokai Univ, Sch Med, Dept Surg, Isehara, Kanagawa 2591193, Japan
[4] Cent Inst Expt Anim, Kawasaki, Kanagawa 2100821, Japan
[5] Tokai Univ, Hachioji Hosp, Dept Surg, Hachioji, Tokyo 1920032, Japan
[6] Shimadzu Co Ltd, Global Applicat Dev Ctr, Kyoto 6048511, Japan
[7] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan
[8] Natl Canc Ctr, Res Inst, Div Hepatobiliary & Pancreat Surg, Tokyo 1040045, Japan
[9] Tokai Univ, Sch Med, Dept Regenerat Med, Isehara, Kanagawa 2591193, Japan
关键词
zinc finger protein 185; pancreatic ductal carcinoma; prognosis; hematogenous metastasis; subcellular location; LIVER METASTASIS; COLON-CANCER; PAXILLIN; GEMCITABINE; PROTEIN;
D O I
10.3892/ol.2017.6633
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pancreatic ductal carcinoma (PDC) is one of the major causes of cancer-associated mortality globally due to its high potential for distant metastasis. To understand hematogenous metastasis, the molecular expression profiles of weak metastatic PDC cell subline BxPC-3 and highly liver-metastatic cell subline LM-BxPC-3 were compared, and zinc finger protein 185 (ZNF185) was identified as a molecule that is upregulated in LM-BxPC-3 cells. The aim of the present study was to evaluate the clinicopathological significance of ZNF185 in PDC. Using immunohistochemistry, ZNF185 expression was investigated in 182 patients with PDC, in association with numerous clinicopathological variables. The expression profile of ZNF185 was also characterized using xenograft models. In contrast to parent BxPC-3 cells in subcutaneous transplanted tumor foci, which only expressed ZNF185 on their plasma membrane (m)ZNF185, LM-BxPC-3 cells in liver-metastatic foci that were formed subsequent to transplantation all expressed cytoplasmic (c)ZNF185. Additionally, 51% of the cells at the periphery of the tumor foci expressed mZNF185. Expression of cZNF185, and of mZNF185 and cZNF185 combined was identified in 93 and 39% of clinical patients with PDC, respectively. Patients with mZNF185-negative and-positive PDC exhibited a median survival time of 30.2 months and 21.3 months, respectively. Multivariate analysis indicated that the expression of mZNF185 is closely associated with a shorter overall survival time. Increased marked venous invasion was more prevalent in patients who were mZNF185-positive, as compared with patients who were mZNF185-negative. These data suggest that the expression of mZNF185 is an independent and unfavorable prognosticator in patients with PDC. The results suggested that the amount and subcellular location of ZNF185 are correlated with the position of the cancer cells expressing it within the nests. Additionally, the subcellular location of ZNF185 may be important to its biological function.
引用
收藏
页码:3633 / 3640
页数:8
相关论文
共 50 条
  • [21] Clinicopathologic features and prognostic implications of MYBL2 protein expression in pancreatic ductal adenocarcinoma
    Yu, Ranjie
    Li, Chengyi
    Lin, Xiaomei
    Chen, Qun
    Li, Jie
    Song, Li
    Lin, Lin
    Liu, Jingnan
    Zhang, Yan
    Kong, Wencui
    Ouyang, Xuenong
    Chen, Xiong
    PATHOLOGY RESEARCH AND PRACTICE, 2017, 213 (08) : 964 - 968
  • [22] Prognostic Significance of HER-2/neu Expression in Patients with Ductal Carcinoma In Situ
    Stackievicz, Rodica
    Paran, Haim
    Bernheim, Joelle
    Shapira, Mayra
    Weisenberg, Neomy
    Kaufman, Tzvi
    Klein, Ehud
    Gutman, Mordechai
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2010, 12 (05): : 290 - 295
  • [23] Expression of LRP16 in pancreatic ductal adenocarcinoma and its clinicopathological significance and prognostic value
    Huang, Yong
    An, Xiaojing
    Zhao, Po
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (06): : 6918 - 6923
  • [24] Cytoglobin as a Prognostic Factor for Pancreatic Ductal Adenocarcinoma A Retrospective Analysis of 75 Patients
    Kono, Hiroshi
    Hosomura, Naohiro
    Amemiya, Hidetake
    Kawaida, Hiromichi
    Furuya, Shinji
    Akaike, Hidenori
    Kawaguchi, Yoshihiko
    Sudo, Makoto
    Ichikawa, Daisuke
    PANCREAS, 2021, 50 (07) : 994 - 999
  • [25] Expression of EGF and EGFR strongly correlates with metastasis of pancreatic ductal carcinoma
    Pryczynicz, Anna
    Guzinska-Ustymowicz, Katarzyna
    Kemona, Andrzej
    Czyewska, Jolanta
    ANTICANCER RESEARCH, 2008, 28 (2B) : 1399 - 1404
  • [26] Clinicopathological significance of fatty acid synthase expression in pancreatic ductal carcinoma
    Maekawa, Hiroshi
    Ito, Tomoaki
    Orita, Hajime
    Sato, Koichi
    Wada, Ryo
    INTERNATIONAL JOURNAL OF HEPATOBILIARY AND PANCREATIC DISEASES, 2013, 3 (01): : 10 - 16
  • [27] MTA2 expression is a novel prognostic marker for pancreatic ductal adenocarcinoma
    Chen, Da-Wei
    Fan, Yao-Fu
    Li, Jiang
    Jiang, Xiao-Xiao
    TUMOR BIOLOGY, 2013, 34 (03) : 1553 - 1557
  • [28] Prognostic Significance of ZKSCAN3 (ZNF306) Expression in Gastric Carcinoma
    Takano, Yuta
    Shida, Atsuo
    Fujisaki, Muneharu
    Mitsumori, Norio
    Yanaga, Katsuhiko
    ANTICANCER RESEARCH, 2020, 40 (01) : 81 - 86
  • [29] Trefoil factor family 1 expression in the invasion front is a poor prognostic factor associated with lymph node metastasis in pancreatic cancer
    Sunagawa, Masaki
    Yamaguchi, Junpei
    Kokuryo, Toshio
    Ebata, Tomoki
    Yokoyama, Yukihiro
    Sugawara, Gen
    Nagino, Masato
    PANCREATOLOGY, 2017, 17 (05) : 782 - 787
  • [30] Expression of SNAIL in accompanying PanIN is a key prognostic indicator in pancreatic ductal adenocarcinomas
    Fujiwara, Sho
    Saiki, Yuriko
    Ishizawa, Kota
    Fukushige, Shinichi
    Yamanaka, Mie
    Sato, Masaki
    Ishida, Masaharu
    Motoi, Fuyuhiko
    Unno, Michiaki
    Horii, Akira
    CANCER MEDICINE, 2019, 8 (04): : 1671 - 1678